Continuous infusion of vancomycin is less toxic than intermittent infusion. It’s time to act.

Retrospective multicentre matched cohort study comparing safety and efficacy outcomes of intermittent-infusion versus continuous-infusion vancomycin.

  • Kang CK, et al.
  • Rédigé par : Dr Jean-Pierre Bru
Numerous consensus guidelines recommend intermittent-infusion vancomycin (IIV) at 15–20 mg/kg every 8–12 h in patients with complicated Staphylococcus aureus infections, and trough concentrations of 15-20mg/L as surrogate marker for AUC24/MIC≥400mg.h/L. The incidence of vancomycin-associated nephrotoxicity in patients with troughs of 15–20mg/L is approximately 20%. The objective of the study wa...
Ce contenu est à destination des professionnels de santé. Merci de vous identifier.
This content is intended for healthcare professionals. Thank you for identifying yourself.

Déjà inscrit / Already registered ?

Créer un compte / Create an account

Créer un compte ne prend que quelques minutes et vous permettra d'accèder à l'ensemble des contenus du site.
Creating an account takes only instant and will allow you to access all the content of the website.